Citation: M. Vooijs et al., FLP-MEDIATED TISSUE-SPECIFIC INACTIVATION OF THE RETINOBLASTOMA TUMOR-SUPPRESSOR GENE IN THE MOUSE, Oncogene, 17(1), 1998, pp. 1-12
Authors:
MORI N
VANWEZEL T
VANDERVALK M
YAMATE J
SAKUMA S
OKUMOTO M
DEMANT P
Citation: N. Mori et al., GENETICS OF SUSCEPTIBILITY TO RADIATION-INDUCED APOPTOSIS IN COLON - 2 LOCI ON CHROMOSOME-9 AND CHROMOSOME-16, Mammalian genome, 9(5), 1998, pp. 377-380
Authors:
VANTELLINGEN O
SCHAAF LJ
PUNT CJA
AWADA A
VANDERVALK M
HENRAR REC
WAGENER DJT
PICCART MJ
NOOIJEN WJ
BEIJNEN JH
Citation: O. Vantellingen et al., IN-VITRO AND IN-VIVO BONE-MARROW TOXICITY ASSAYS IN THE CLINICAL DEVELOPMENT OF NEW DRUGS - CARZELESIN AS AN EXAMPLE, Annals of oncology, 9, 1998, pp. 204-204
Authors:
ROBANUSMAANDAG E
DEKKER M
VANDERVALK M
CARROZZA ML
JEANNY JC
DANNENBERG JH
BERNS A
RIELE HT
Citation: E. Robanusmaandag et al., P107 IS A SUPPRESSOR OF RETINOBLASTOMA DEVELOPMENT IN PRB-DEFICIENT MICE, Genes & development, 12(11), 1998, pp. 1599-1609
Authors:
WIJNHOLDS J
SCHEFFER GL
VANDERVALK M
VANDERVALK P
BEIJNEN JH
SCHEPER RJ
BORST P
Citation: J. Wijnholds et al., MULTIDRUG-RESISTANCE PROTEIN-1 PROTECTS THE OROPHARYNGEAL MUCOSAL LAYER AND THE TESTICULAR TUBULES AGAINST DRUG-INDUCED DAMAGE, The Journal of experimental medicine, 188(5), 1998, pp. 797-808
Authors:
VANTELLINGEN O
NOOIJEN WJ
SCHAAF LJ
VANDERVALK M
VANASPEREN J
HENRAR REC
BEIJNEN JH
Citation: O. Vantellingen et al., COMPARATIVE PHARMACOLOGY OF THE NOVEL CYCLOPROPYLPYRROLOINDOLE-PRODRUG CARZELESIN IN MICE, RATS, AND HUMANS, Cancer research, 58(11), 1998, pp. 2410-2416
Authors:
WIJNHOLDS J
EVERS R
VANLEUSDEN MR
MOL CAAM
ZAMAN GJR
MAYER U
BEIJNEN JH
VANDERVALK M
KRIMPENFORT P
BORST P
Citation: J. Wijnholds et al., INCREASED SENSITIVITY TO ANTICANCER DRUGS AND DECREASED INFLAMMATORY RESPONSE IN MICE LACKING THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN, Nature medicine, 3(11), 1997, pp. 1275-1279
Authors:
VANDERLUGT NMT
DOMEN J
LINDERS K
VANROON M
ROBANUSMAANDAG E
TERIELE H
VANDERVALK M
DESCHAMPS J
SOFRONIEW M
VANLOHUIZEN M
BERNS A
Citation: Nmt. Vanderlugt et al., POSTERIOR TRANSFORMATION, NEUROLOGICAL ABNORMALITIES, AND SEVERE HEMATOPOIETIC DEFECTS IN MICE WITH A TARGETED DELETION OF THE BMI-1 PROTOONCOGENE, Genes & development, 8(7), 1994, pp. 757-769
Authors:
MAANDAG ECR
VANDERVALK M
VLAAR M
FELTKAMP C
OBRIEN J
VANROON M
VANDERLUGT N
BERNS A
TERIELE H
Citation: Ecr. Maandag et al., DEVELOPMENTAL RESCUE OF AN EMBRYONIC-LETHAL MUTATION IN THE RETINOBLASTOMA GENE IN CHIMERIC MICE, EMBO journal, 13(18), 1994, pp. 4260-4268
Authors:
BAIN G
MAANDAG ECR
IZON DJ
AMSEN D
KRUISBEEK AM
WEINTRAUB BC
KROP I
SCHLISSEL MS
FEENEY AJ
VANROON M
VANDERVALK M
TERIELE HPJ
BERNS A
MURRE C
Citation: G. Bain et al., E2A PROTEINS ARE REQUIRED FOR PROPER B-CELL DEVELOPMENT AND INITIATION OF IMMUNOGLOBULIN GENE REARRANGEMENTS, Cell, 79(5), 1994, pp. 885-892
Authors:
VANDERLUGT NMT
LINDERS K
DOMEN J
VANROON M
ROBANUS E
TERIELE H
VANLOHUIZEN M
VANDERVALK M
BERNS A
Citation: Nmt. Vanderlugt et al., INACTIVATION OF THE BMI-1 ONCOGENE IN MICE RESULTS IN SEVERE HEMATOPOIETIC DEFECTS AND NEUROLOGICAL ABNORMALITY, Journal of cellular biochemistry, 1993, pp. 267-267